Fifth Third Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Sell
969
-210
-18% -$118K 0.01% 475
2026
Q1
$662K Buy
1,179
+287
+32% +$184K 0.02% 345
2025
Q4
$603K Sell
892
-23
-3% -$15.7K 0.02% 346
2025
Q3
$585K Buy
915
+14
+2% +$8.5K 0.02% 335
2025
Q2
$483K Sell
901
-94
-9% -$45K 0.02% 375
2025
Q1
$418K Buy
995
+11
+1% +$4.78K 0.02% 378
2024
Q4
$407K Buy
984
+149
+18% +$65.4K 0.02% 390
2024
Q3
$422K Buy
835
+83
+11% +$40.3K 0.03% 354
2024
Q2
$366K Buy
+752
New +$378K 0.03% 359

Other funds holding IDXX

Fifth Third Wealth Advisors's IDXX Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $118K and leaving 969 shares worth $510K. The position accounts for 0.01% of the portfolio, ranked #475.

Fifth Third Wealth Advisors first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $662K in Q1 2026. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Fifth Third Wealth Advisors held 969 shares of Idexx Laboratories worth $510K as of Q2 2026.
  • Fifth Third Wealth Advisors sold 210 Idexx Laboratories shares in Q2 2026, an estimated $118K.
  • Idexx Laboratories made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #475 holding.
  • Fifth Third Wealth Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Fifth Third Wealth Advisors's Idexx Laboratories position peaked at $662K in Q1 2026.
  • 235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.